HQY Healthequity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: HQY

Price (delayed)

$94.635

Market cap

$7.91B

P/E Ratio

35.18

Dividend/share

N/A

EPS

$2.69

Enterprise value

$8.63B

?
Relative Growth: Rel. Growth: 88
Relative Strength: Rel. Strength: 56
Relative Valuation: Rel. Valuation: 53
Relative Profitability: Rel. Profitability: 94

HealthEquity and its subsidiaries administer HSAs and other consumer-directed benefits for its more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers who ...

Highlights
HQY's EPS has surged by 92% year-on-year and by 8% since the previous quarter
HQY's net income has surged by 89% year-on-year and by 7% since the previous quarter
HQY's quick ratio is down by 18% year-on-year
The equity has contracted by 3.6% YoY and by 2.8% from the previous quarter
Sector: Healthcare
Industry: Health Information Services
Website: http://www.healthequity.com
Peers: UHAL EZPW

Key stats

What are the main financial stats of HQY

HQY stock price

How has the Healthequity stock price performed over time
Intraday
0.32%
1 week
-3.11%
1 month
11.34%
1 year
0.27%
YTD
3.3%
QTD
4.78%

Financial performance

How have Healthequity's revenue and profit performed over time
Revenue
$1.34B
Gross profit
$945.12M
Operating income
$342.33M
Net income
$230.7M
Gross margin
70.7%
Net margin
17.3%
HQY's net income has surged by 89% year-on-year and by 7% since the previous quarter
The net margin has surged by 77% year-on-year and by 5% since the previous quarter
HQY's operating income has surged by 68% year-on-year and by 6% since the previous quarter
Healthequity's operating margin has soared by 56% YoY and by 4.1% from the previous quarter

Price vs fundamentals

How does HQY's price correlate with its fundamentals

Growth

What is Healthequity's growth rate over time

Valuation

What is Healthequity stock price valuation
HQY P/E details
P/E
35.18
P/B
3.9
P/S
5.97
EV/EBIT
24.4
EV/EBITDA
16.99
EV/Sales
6.45
HQY's EPS has surged by 92% year-on-year and by 8% since the previous quarter
The P/E is 15% lower than the last 4 quarters average of 41.3
The stock's P/B is 22% above its 5-year quarterly average of 3.2 and 8% above its last 4 quarters average of 3.6
The equity has contracted by 3.6% YoY and by 2.8% from the previous quarter
HQY's revenue is up by 8% year-on-year
The stock's price to sales (P/S) is 8% less than its 5-year quarterly average of 6.5

Efficiency

How efficient is Healthequity business performance
The ROA has soared by 94% YoY and by 8% from the previous quarter
The ROE has soared by 91% YoY and by 8% from the previous quarter
HQY's ROIC has soared by 75% YoY and by 8% QoQ
HQY's return on sales has surged by 51% year-on-year and by 3.9% since the previous quarter

Dividends

What is HQY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HQY.

Financial health

How did Healthequity financials performed over time
Healthequity's total assets is 163% higher than its total liabilities
HQY's quick ratio is down by 18% year-on-year
Healthequity's current ratio has decreased by 15% YoY but it has increased by 5% QoQ
The debt is 52% smaller than the equity
The debt has declined by 11% year-on-year
The debt to equity has declined by 8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.